开发纳米结构脂质载体载荷富含黄类丰富的生 officinale
Sharifah Sarah Shazwani1, Anita Marlina1,2, Misni Misran1
1Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur 50603, Malaysia.
ACS omega
|April 22, 2024
概括
这项研究开发了一种使用纳米结构脂质载体 (NLC) 装载生 (Zingiber officinale) 黄的抗炎局部凝. 该NLC凝配方表现出增强的稳定性和均的颗粒分布,提供了一个有前途的局部药物递送系统.
科学领域:
- 药理学和制药学 药理学和制药学
- 自然产品化学 自然产品化学
- 材料科学 材料科学 材料科学
背景情况:
- 来自银杏花的黄酸具有抗氧化和抗炎性质.
- 纳米结构脂质载体 (NLCs) 提高了生物活性化合物的生物可用性和稳定性.
- 局部输送系统旨在提高局部疾病的治疗疗效.
研究的目的:
- 使用NLCs开发一种含有来自Zingiber officinale的黄类的抗炎局部凝.
- 为了评估含有黄的NLC配方的稳定性和特性.
- 评估这种NLC凝作为一种新型局部药物递送系统的潜力.
主要方法:
- 通过热同质化,使用酸,中链甘油三酸,异氨基氨酸,Tween 20和Span 20制备了NLC.
- 总黄酸含量被量化 (4.04 mg QUE/g 干取物).
- 进行了封装效率,颗粒大小,多分散度指数和形态分析.
主要成果:
- 最佳的含有黄的NLC配方实现了2%的生官提取物 (ZOE) 度,以获得最高的封装效率.
- 0.4%的ZOE度在28天后产生了稳定的NLC (302-344 nm粒子大小,0.14-0.23 PDI).
- 形态分析证实了稳定,均的NLC粒子分布.
结论:
- 与传统的凝相比,开发的带有ZOE的NLC凝具有优越的质量稳定性和固态特性.
- 这种NLC配方代表了用于局部应用的有希望的替代药物输送系统.
- 通过NLCs增强黄类药物的稳定性和生物可用性可能会导致改善抗炎治疗效果.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


